2011 PdCCRS - Can exercise ameliorate treatment toxicity Priority-driven during the initial phase of Collaborative testosterone suppression in Cancer Edith Cowan Cancer prostate patients? Is this more $163,634.45 02/02/2012 46 Joondalup, WA 6027 Australia University Research effective than delayed Scheme rehabilitation and what is the time course and persistence of benefits? App1029901 2011 - PdCCRS 'ReCaPTure Priority-driven LiFe': A phase 11 randomised Collaborative Cancer University of New trial of a psychological Cancer $148,811.45 17/02/2012 36 Sydney, NSW 2052 Australia South Wales intervention to support Research adolescent and young adult Scheme cancer survivors. App1022868 2011 - PdCCRS - The role of Priority-driven p53-regulated microRNAs in Collaborative epithelial to mesenchymal Cancer Garvan Institute of Cancer transition, and their potential $24,750.00 17/02/2012 12 Sydney. NSW 2010 Australia Medical Research Research as therapeutic targets against Scheme metastatic breast cancer. App1034561 Priority Driven Collaborative Priority-driven Cancer Research Scheme Collaborative (PDCCRS) 2008: Integrative Cancer Menzies Research Cancer genomic approaches to $567,270 17/02/2012 68 Hobart, TAS 7000 Australia Institute Research understanding the genetics of Scheme prostate cancer. App ID: 544938; Ref: CA-A0809/11 Priority-driven 2011 - PdCCRS -Quantifying Collaborative Cancer University of the impact of imaging choice Cancer $143,585.20 21/02/2012 41 Wollongong, NSW 2522 Australia Wollongong for breast cancer Research radiotherapy. App1033237 Scheme The State of 2011 - PdCCRS - A Queensland randomised Phase III trial of Priority-driven through High Dose Palliative Collaborative Cancer Queensland Radiotherapy (HDPRT) versus Cancer $327,214.80 21/02/2012 72 Woolloongabba, QLD 4102 Australia Health via The concurrent Chemotherapy Research Princess Alexandra and HDPRT (C-HDPRT) in Scheme Hospital Metro patients with Good South District performance Status. Locally
Cancer Australia Priority-driven Collaborative Cancer Research Scheme Edith Cowan University 2011 PdCCRS - Can exercise ameliorate treatment toxicity during the initial phase of testosterone suppression in prostate patients? Is this more effective than delayed rehabilitation and what is the time course and persistence of benefits? App1029901 $163,634.45 02/02/2012 46 Joondalup, WA 6027 Cancer Australia Priority-driven Collaborative Cancer Research Scheme University of New South Wales 2011 - PdCCRS 'ReCaPTure LiFe': A phase 11 randomised trial of a psychological intervention to support adolescent and young adult cancer survivors. App1022868 $148,811.45 17/02/2012 36 Sydney, NSW 2052 Cancer Australia Priority-driven Collaborative Cancer Research Scheme Garvan Institute of Medical Research 2011 - PdCCRS - The role of p53-regulated microRNAs in epithelial to mesenchymal transition, and their potential as therapeutic targets against metastatic breast cancer. App1034561 $24,750.00 17/02/2012 12 Sydney. NSW 2010 Cancer Australia Priority-driven Collaborative Cancer Research Scheme Menzies Research Institute Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Integrative genomic approaches to understanding the genetics of prostate cancer. App ID: 544938; Ref: CA-A0809/11 $567,270 17/02/2012 68 Hobart, TAS 7000 Cancer Australia Priority-driven Collaborative Cancer Research Scheme University of Wollongong 2011 - PdCCRS -Quantifying the impact of imaging choice for breast cancer radiotherapy. App1033237 $143,585.20 21/02/2012 41 Wollongong, NSW 2522 Cancer Australia Priority-driven Collaborative Cancer Research Scheme The State of Queensland through Queensland Health via The Princess Alexandra Hospital Metro South District 2011 - PdCCRS - A randomised Phase III trial of High Dose Palliative Radiotherapy (HDPRT) versus concurrent Chemotherapy and HDPRT (C-HDPRT) in patients with Good performance Status. Locally $327,214.80 21/02/2012 72 Woolloongabba, QLD 4102
grants_reporting_20170703_3.docx